16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis
Clinical trial NCT01358175 · COMPLETED
Trial details
- NCT number
- NCT01358175
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2014-12-01
- Enrollment
- 371
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.